Crowdsourcing is a promising approach to biomedical research and development (R&D) and could produce solutions to pandemics like this one.
Academic rigor, journalistic flair
Articles on Biomedical research
Displaying 21 - 40 of 48 articles
Predicting life expectancy remains in the realm of science fiction, but it may soon be possible. Are we prepared for such information? And who else would benefit from this knowledge?
Canada’s systems of health funding, medical training and physician compensation need an overhaul – to support vital centres of medical research and complex care.
Basic research can be easy to mock as pointless and wasteful of resources. But it’s very often the foundation for future innovation – even in ways the original scientists couldn’t have imagined.
Scientists are rewarded with funding and publications when they come up with innovative findings. But in the midst of a ‘reproducibility crisis,’ being new isn’t the only thing to value about research.
Affirmative action programs at universities are under threat by the Trump administration. That could be especially damaging to medical education. Who knows who holds the idea for the next great cure?
Holding patents can be a lucrative and powerful position to be in. Here’s a proposal for how nonprofit patent holders can do more for the common good – and live up to their end of the tax break bargain.
Lowering the threshold for FDA approval and feeding the agency less rigorous information will increase the likelihood of approvals of unsafe or ineffective drugs and devices.
The outgoing president leaves behind some solid accomplishments in the world of science, tech and medicine. But the biggest departure from his predecessors might have been in his approach.
The traditional mode of publishing scientific research faces much criticism – primarily for being too slow and sometimes shoddily done. Maybe fewer publications of higher quality is the way forward.
The recent NHMRC funding announcement has renewed criticism about how medical research is funded in Australia. Is the system fair? Or is it stacked against some researchers?
Regulations, funding and public opinion around genetically enhancing future generations vary from country to country. Here’s why China may be poised to be the pioneer.
The rise of personalised medicine, which is mainly based on genetic testing, needs adequate regulation so privacy rights aren’t breached. That’s only one of several issues that must be considered.
Fruit flies aren’t just a remarkable organism for research. They are also central to a project that aims to provide more at-home research opportunities for African scientists.
Human guinea pigs? On the occasion of Rennes drama, an explanation of what the drug trials in France and how they are controlled.
Meta-analyses that combine many different studies are the gold standard for medical evidence. But they are only as good research they examine.
Today’s medical students are tomorrow’s doctors, and they need to understand public health to better help their patients.
US row might suggest using feotal tissue is new - in fact it’s not only a long-held practice, but essential for many medical breakthroughs.
By forgetting that medicine postpones death rather than saving lives, we persuade ourselves it might somehow keep extending our life and come to view death as a failure of medicine.
It’s been a great privilege to have been the head of NHMRC for going on a decade. That’s four governments, six health ministers, a funding increase from A$437 million in 2006 to A$859 million today.
Top contributors
-
Membre du comité d'éthique de l'Inserm, Inserm
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Director of Translational Institute of Medicine (TIME), Queen's University, Ontario
-
Associate Professor of General Pediatrics, University of Florida
-
Professor of Obstetrics and Gynecology, Thomas Jefferson University
-
Senior Lecturer and Co-Director, Policy Ethics and Life Sciences Research Centre, Newcastle University
-
Research officer, Macquarie University
-
Professor of Physiology, Columbia University
-
Associate Professor, Faculty of Law, University of Technology Sydney
-
Associate Professor, Dept of Global Health; Infectious Diseases Specialist, Boston University
-
Lecturer, Department of Zoology, University of Cambridge
-
Professor and NHMRC Investigator Fellow, Institute for Glycomics, Griffith University
-
Secretary-General, International Human Frontier Science Program Organisation; Emeritus Professor, Monash University, Monash University
-
Associate Professor of Biological Sciences, University of Maryland, Baltimore County
-
Assistant Professor, Bond University
